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Letters to the Editorand data from other investigators,3,5 the
pressure gradients of inflow (negative
pressure) and outflow (positive pressure)
are for all flow regimens and cannula
dimensions greater in a bilumen cannula
than in the c configuration setting.
This value is critical above 4.5 to 5
L/min with the largest (31F) Avalon
cannula. The clinical implications and
biologic effects of elevated positive
and negative pressure gradients are
not clear yet; however, from our data
they seem to negatively affect the
coagulation system, platelet function,
phlogistic system, and blood cells.
Major incidences of some complication,
such as hemolysis, low platelet count,
and coagulation status alteration, with
the Avalon Elite cannula versus the
c configuration seem to be correlated
with differences in the pressures
regimen.3-5
Cannula diameter: The adult bi-
lumen Avalon Elite cannula is large
and may almost completely occlude
the jugular vein and the first portion
of the superior vena cava. In our
experience, the incidence of large
thrombosis of jugular and subcla-
vian veins is very high (nearly
80% of our patients; unpublished
data).
Cannula cost:Last, but not least, the
bicaval dual-lumen catheter (AvalonNotice of Correction
The JournalElite) is several times more expensive
than the c configuration strategy.
In conclusion, the Avalon Elite bi-
lumen cannula does improve venove-
nous ECMO treatment and is the
ideal device for selected patients. We
believe that it is not the optimal tool
in all cases, however, and actually
the adult bilumen cannula seems inad-
equate for venovenous ECMO in
a range of patients with refractory re-
spiratory insufficiency, such as larger
patients with severely impaired pul-
monary function and patients with hy-
perdynamic status.
As an alternative, the c configura-
tion can be applied in nearly all
cases, irrespective of corporeal di-
mensions, and can guarantee efficient
and effective extracorporeal blood
oxygenation with very low RBF and
very high oxygen delivery levels, al-
lowing protective ventilator settings
when trying to achieve lung rest,
avoiding overall ventilator-Induced
lung injury and consequently reduc-
ing ECMO time, time to pulmonary
recovery, the intensive care unit
stay, adverse patient outcomes, and
hospital costs.1
Finally, we believe that the reported
c configuration strategy is an important
resource for achieving optimal venove-
nous ECMO in different patients, that itof Thoracic and Cardiovascular Surgeis associated with excellent postopera-
tive outcomes, and that it should be
part of the ‘‘ECMO armamentarium’’
in advanced ECMO centers to ensure
the best treatment for the individual
patient’s characteristics.
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In the above-mentioned article, the reported time period of the study was incorrect. The study period began in 1999 and not in
2004. The first sentence of the ‘‘Methods’’ section in the abstract is corrected as follows: From 1999 to 2009, 4314 patients
underwent myocardial revascularization. The first sentence of the ‘‘Patients and Methods’’ section is corrected as follows:
From 1999 to 2009, 4314 patients underwent myocardial revascularization at our institution.ry c Volume 143, Number 4 995
